SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-05-035624
Filing Date
2005-07-06
Accepted
2005-07-06 15:35:58
Documents
1
Period of Report
2005-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 16478
  Complete submission text file 0001209191-05-035624.txt   18429
Mailing Address 6611 TRIBUTARY STREET BALTIMORE MD 21224
Business Address 6611 TRIBUTARY STREET BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Issuer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GUILFORD PHARMACEUTICALS INC 6611 TIBUTARY ST. BALTIMORE MD 21224
Business Address 6611 TRIBUTARY STREET C/O GUILFORD PHARMACEUTICALS INC BALTIMORE MD 21224 4106316300
BUNTING GEORGE L JR (Reporting) CIK: 0001206361 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23736 | Film No.: 05940541